Offer - Urjas Oil for just ₹ 1 X
Gemfos 35 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of Post Menopausal Osteoporosis. Secondary and off-label uses of Gemfos 35 Tablet have also been mentioned below.
The optimal dosage of Gemfos 35 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Gemfos 35 Tablet include Musculoskeletal Pain (Bone, Muscle or Joint). While these are the most often observed Gemfos 35 Tablet side effects, there are can be others also. These have been listed below. These side effects of Gemfos 35 Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Gemfos 35 Tablet's effect during pregnancy is Severe and Moderate while nursing. In addition, Gemfos 35 Tablet's effects on the liver, heart and kidney are discussed below in the Gemfos 35 Tablet related warnings section.
Gemfos 35 Tablet is contraindicated in people with pre-existing medical conditions like Infections, Gastritis, Peptic Ulcer as it can result in adverse effects. Other conditions have been mentioned below in the Gemfos 35 Tablet contraindications section.
Drug reaction of Gemfos 35 Tablet with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Gemfos 35 Tablet is considered safe while driving, and is addictive.
Gemfos 35 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gemfos 35 Tablet safe for pregnant women?
Gemfos shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Gemfos 35 Tablet safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Gemfos. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Gemfos 35 Tablet on the Kidneys?
Kidney can be affected by Gemfos. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Gemfos 35 Tablet on the Liver?
Gemfos is rarely harmful for the liver.
What is the effect of Gemfos 35 Tablet on the Heart?
Gemfos has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Gemfos 35 Tablet unless your doctor advises you to do so -
Is this Gemfos 35 Tablet habit forming or addictive?
Gemfos 35 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Gemfos 35 Tablet as it does not make you drowsy.
Is it safe?
Yes, but consume Gemfos 35 Tablet only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Gemfos 35 Tablet for mental disorders.
Interaction between Food and Gemfos 35 Tablet
Due to the absence of research, it is difficult to say how Gemfos 35 Tablet and food will interact.
Interaction between Alcohol and Gemfos 35 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Gemfos 35 Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actonel® (risedronate sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 1099-1102
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1099-1102